India · Delayed Price · Currency is INR Wanbury Company Description
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally.
It offers formulations for anti-infectives, pain and analgesics, gastroenterology, rheumatology, respiratory, gynecology, and central nervous system, as well as for vitamins, minerals, and nutrition.
The company also provides API products for antidiabetics, antidepressants, anti-histaminic, anaesthetic, anti-inflammatory, anti-coagulant, GERD, and gastric ulcer therapy, as well as antitussives and analgesics.
Its API portfolio includes Metformin Hcl, Sertraline Hcl, Tramadol Hcl, Mefenamic Acid , Metformin Hcl DC, Diphenhydramine Citrate, Paroxetine, Diphenhydramine Hcl, and Anaesthetic API.
The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004.
Wanbury Limited was founded in 1988 and is headquartered in Navi Mumbai, India.
| Country | India |
| Founded | 1988 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,200 |
| CEO | Mohan Rayana |
Contact Details
Address: BSEL Tech Park Navi Mumbai, Maharashtra 400703 India | |
| Phone | 91 22 6794 2222 |
| Website | wanbury.com |
Stock Details
| Ticker Symbol | WANBURY |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE107F01022 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Pradeep Patni | Chief Executive Officer of India Formulation Business |
| Mohan Kumar Rayana | Whole Time Director |
| Vinod R. Verma | Chief Financial Officer |
| Jitendra Jayantilal Gandhi | Compliance Officer and Company Secretary |
| Dr. Shireesh Bhalchandra Ambhaikar | President of Operations - API Business |
| Nanasaheb Gunjal | Senior Vice President of QA,QC and RA |
| Prakash Venkataraman B.E., MBA | Head of API Business |